Abstract
摘要
相似文献
1
[Renal cell carcinoma].
Gan To Kagaku Ryoho. 2010 Jan;37(1):29-31.
2
Editorial comment.
Urology. 2010 May;75(5):1114; author reply 1115. doi: 10.1016/j.urology.2009.07.1290.
3
Editorial comment.
Urology. 2010 May;75(5):1114-5; author reply 1115. doi: 10.1016/j.urology.2009.07.1291.
4
CCR drug updates: sorafenib and sunitinib in renal cell carcinoma.
Clin Cancer Res. 2007 Jul 1;13(13):3765-70. doi: 10.1158/1078-0432.CCR-06-2844.
5
Two new drugs for renal cell carcinoma.
Med Lett Drugs Ther. 2007 Feb 26;49(1255):18-20.
6
Genetic basis of kidney cancer: a model for developing molecular-targeted therapies.
BJU Int. 2007 May;99(5 Pt B):1223-9. doi: 10.1111/j.1464-410X.2007.06814.x.
7
New therapeutic options for renal cell carcinoma.
Clin Adv Hematol Oncol. 2006 Jun;4(6):429-30.
8
[New therapeutic regimes in metastasic renal-cell carcinoma].
Internist (Berl). 2008 Jan;49(1):114-7. doi: 10.1007/s00108-007-1972-0.
9
Trials probe new agents for kidney cancer.
JAMA. 2006 Jul 12;296(2):155-7. doi: 10.1001/jama.296.2.155.
10
Therapy for metastatic RCC--questions remain.
Nat Rev Urol. 2009 Nov;6(11):580-1. doi: 10.1038/nrurol.2009.210.
Zotero 插件